Although we observed a drop of CD14 + CCR2+ IM in peripheral blood, a decrease of CCR2+ TAM in the tumor was only observed for two patients and is inadequate to support a definitive conclusion about this component of the mechanism of action. This evidence concerns the gene CD14 and neoplasm.